A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MEKi

Search Conditions:
Search Keyword : MEKi
Search Method : Exact match.
Research Area:

Abbreviation: MEKi
Appearance Frequency: 115 time(s)
Long forms: 7

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
MEK inhibitors
(55 times)
(37 times)
BRAFi (19 times)
MAPK (8 times)
NF1 (4 times)
2013 MEK in cancer and cancer therapy.
MEK inhibitor
(54 times)
(36 times)
BRAFi (20 times)
PFS (6 times)
OS (4 times)
2012 The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition.
mitogen-activated protein kinase inhibitors
(2 times)
(1 time)
BRAFi (1 time)
MM (1 time)
R/R (1 time)
2020 Combination of Dabrafenib and Trametinib for the Treatment of Relapsed and Refractory Multiple Myeloma Harboring BRAF V600E Mutation.
MEK inhibitor, PD-0325901
(1 time)
(1 time)
METi (1 time)
RAFi (1 time)
2012 A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation.
MEK kinase inhibitors
(1 time)
(1 time)
BRAFi (1 time)
DeCOG (1 time)
MAPK (1 time)
2013 Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients.
Mitogen Activated Kinase inhibitors
(1 time)
(1 time)
--- 2018 Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors.
mitogen-activated protein kinase kinase
(1 time)
(1 time)
4-NC (2 times)
ER (1 time)
2018 ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC).